OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade‐Delmas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 998-998
Open Access | Times Cited: 6
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade‐Delmas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 998-998
Open Access | Times Cited: 6
Showing 6 citing articles:
Synthesis of New 5- or 7-Substituted 3-Nitroimidazo[1,2-a]pyridine Derivatives Using SNAr and Palladium-Catalyzed Reactions To Explore Antiparasitic Structure–Activity Relationships
Nicolas Primas, Patrice Vanelle, Romain Paoli-Lombardo, et al.
Synthesis (2023) Vol. 56, Iss. 08, pp. 1297-1308
Open Access | Times Cited: 2
Nicolas Primas, Patrice Vanelle, Romain Paoli-Lombardo, et al.
Synthesis (2023) Vol. 56, Iss. 08, pp. 1297-1308
Open Access | Times Cited: 2
31st Annual GP2A Medicinal Chemistry Conference
Nicolas Primas, Caroline Castera‐Ducros, Romain Paoli-Lombardo, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 209-243
Open Access
Nicolas Primas, Caroline Castera‐Ducros, Romain Paoli-Lombardo, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 209-243
Open Access
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 878-878
Open Access
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 878-878
Open Access
Structural simplification of the 3‐nitroimidazo[1,2‐a]pyridine antileishmanial pharmacophore: Design, synthesis, and antileishmanial activity of novel 2,4-disubstituted 5-nitroimidazoles
Romain Paoli-Lombardo, Nicolas Primas, Sébastien Hutter, et al.
Heterocyclic Communications (2024) Vol. 30, Iss. 1
Open Access
Romain Paoli-Lombardo, Nicolas Primas, Sébastien Hutter, et al.
Heterocyclic Communications (2024) Vol. 30, Iss. 1
Open Access
Design, Synthesis, and Evaluation of Trihalomethyl Ketone Derivatives of Neocarzilin A as Improved Antimetastatic Agents
Noah M. Moriarty, Annaleigh Benton, Lauren E. Gartenhaus, et al.
ACS Bio & Med Chem Au (2024) Vol. 4, Iss. 6, pp. 331-341
Open Access
Noah M. Moriarty, Annaleigh Benton, Lauren E. Gartenhaus, et al.
ACS Bio & Med Chem Au (2024) Vol. 4, Iss. 6, pp. 331-341
Open Access
2,2′-[2,4-Bis(4-chlorophenyl)cyclobutane-1,3-diyl]bis(8-bromo-6-chloro-3-nitroimidazo[1,2-a]pyridine)
Inès Jacquet, Romain Paoli-Lombardo, Caroline Castera‐Ducros, et al.
Molbank (2024) Vol. 2024, Iss. 4, pp. M1916-M1916
Open Access
Inès Jacquet, Romain Paoli-Lombardo, Caroline Castera‐Ducros, et al.
Molbank (2024) Vol. 2024, Iss. 4, pp. M1916-M1916
Open Access
